BBH

Tactical Allocation Channel

Biotech ETFs Could Use Some Mergers & Acquisitions

By Tom LydonMay 17, 2019

Equity ETFs

Biotech ETFs Climb on Biogen’s Promising Clinical Trial

By Max ChenJuly 6, 2018

Investing

Try This ETF Pair to Round Out Biotech Exposure

By David DierkingMarch 23, 2018

Equity ETFs

Biotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from Obamacare

By Max ChenJanuary 4, 2017

Equity ETFs

Rising Rates May Hurt Small-Cap Biotech ETF Valuations

By Max ChenDecember 23, 2016

Equity ETFs

10 Best & Worst ETF Performers of the Day (May 11)

By Brenton GarenMay 11, 2016

Equity ETFs

Hit The Lab With These 17 Biotech ETFs

By Tom LydonMay 2, 2016

Equity ETFs

A Cheap ETF Sector Play

By Max ChenMarch 21, 2016

New ETFs

ETF News and Views

By Tom LydonFebruary 23, 2016

Equity ETFs

Disappointing Drug Trials Drag on Biotech ETFs

By Tom LydonJanuary 21, 2016

Featured

ETF Providers Diversifying with Exchange Listings

By Tom LydonJanuary 13, 2016

Contributed

ETF Chart of the Day: Hot Biotechnology Sector

By Paul Weisbruch, Street One FinancialJuly 30, 2015

Featured

Biotech Hedge Funds are hot, but Biotech ETFs are Hotter

By Todd ShriberMay 29, 2015

Featured

An ETF for Hedge Funds’ Favorite Biotechs

By Todd ShriberMay 27, 2015

Featured

Biotech ETFs are not out for Summer

By Todd ShriberMay 26, 2015

Featured

Biogen Boosts Biotech ETFs to More New Highs

By Todd ShriberMarch 20, 2015

Featured

ETFs for the Next Biotech Takeover Targets

By Todd ShriberMarch 10, 2015

Featured

A Biotech ETF Right for Oncology Mergers and Acquisitions

By Todd ShriberMarch 9, 2015